Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
British Medical Journal: "Centers for Disease Control and Prevention: protecting the private good?"
http://www.bmj.com/content/350/bmj.h2362
Centers for Disease Control and Prevention: protecting the private good?
by Jeanne Lenzer, associate editor, The BMJ, USA
BMJ 2015; 350 doi: http://dx.doi.org/10.1136/bmj.h2362 (Published 15 May 2015)
Cite this as: BMJ 2015;350:h2362
After revelations that the CDC is receiving some funding from industry, Jeanne Lenzer investigates how it might have affected the organisations decisions
The Centers for Disease Control and Prevention (CDC) includes the following disclaimer with its recommendations: CDC, our planners, and our content experts wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products . . . CDC does not accept commercial support.1
The CDCs image as an independent watchdog over the public health has given it enormous prestige, and its recommendations are occasionally enforced by law.
Despite the agencys disclaimer, the CDC does receive millions of dollars in industry gifts and funding, both directly and indirectly, and several recent CDC actions and recommendations have raised questions about the science it cites, the clinical guidelines it promotes, and the money it is taking.
Marcia Angell, former editor in chief of the New England Journal of Medicine, told The BMJ, The CDC has enormous credibility among physicians, in no small part because the agency is generally thought to be free of industry bias. Financial dealings with biopharmaceutical companies threaten that reputation.2
Industry funding of the CDC has taken many doctors, even some who worked for CDC, by surprise. Philip Lederer, an infectious diseases fellow at Massachusetts General Hospital and Brigham and Womens Hospital in Boston, Massachusetts, and a former CDC epidemic intelligence service officer, told The BMJ he was saddened to learn of industry funding.
The CDCs director, Tom Frieden, did not respond to a question about the disclaimer. He told The BMJ by email, Public-private partnerships allow CDC to do more, faster. The agencys core values of accountability, respect, and integrity guide the way CDC spends the funds entrusted to it. When possible conflicts of interests arise, we take a hard, close look to ensure that proper policies and guidelines are followed before accepting outside donations.
<>
Centers for Disease Control and Prevention: protecting the private good?
by Jeanne Lenzer, associate editor, The BMJ, USA
BMJ 2015; 350 doi: http://dx.doi.org/10.1136/bmj.h2362 (Published 15 May 2015)
Cite this as: BMJ 2015;350:h2362
After revelations that the CDC is receiving some funding from industry, Jeanne Lenzer investigates how it might have affected the organisations decisions
The Centers for Disease Control and Prevention (CDC) includes the following disclaimer with its recommendations: CDC, our planners, and our content experts wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products . . . CDC does not accept commercial support.1
The CDCs image as an independent watchdog over the public health has given it enormous prestige, and its recommendations are occasionally enforced by law.
Despite the agencys disclaimer, the CDC does receive millions of dollars in industry gifts and funding, both directly and indirectly, and several recent CDC actions and recommendations have raised questions about the science it cites, the clinical guidelines it promotes, and the money it is taking.
Marcia Angell, former editor in chief of the New England Journal of Medicine, told The BMJ, The CDC has enormous credibility among physicians, in no small part because the agency is generally thought to be free of industry bias. Financial dealings with biopharmaceutical companies threaten that reputation.2
Industry funding of the CDC has taken many doctors, even some who worked for CDC, by surprise. Philip Lederer, an infectious diseases fellow at Massachusetts General Hospital and Brigham and Womens Hospital in Boston, Massachusetts, and a former CDC epidemic intelligence service officer, told The BMJ he was saddened to learn of industry funding.
The CDCs director, Tom Frieden, did not respond to a question about the disclaimer. He told The BMJ by email, Public-private partnerships allow CDC to do more, faster. The agencys core values of accountability, respect, and integrity guide the way CDC spends the funds entrusted to it. When possible conflicts of interests arise, we take a hard, close look to ensure that proper policies and guidelines are followed before accepting outside donations.
<>
Oh, snap.
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
2 replies, 1189 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (9)
ReplyReply to this post
2 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
British Medical Journal: "Centers for Disease Control and Prevention: protecting the private good?" (Original Post)
proverbialwisdom
Jun 2015
OP
Chakaconcarne
(2,460 posts)1. Surprise...surprise...
and you wonder why people are losing confidence in the things they regulate.
bobthedrummer
(26,083 posts)2. K&R + a link to Physicians for Human Rights website